Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
暂无分享，去创建一个
I. Ellis | E. Provenzano | S. Pinder | E. Rakha | C. Quinn | S. Shiino | C. Purdie | S. Kurozumi | T. Oyama | M. Toss | I. Miligy | A. Shaaban | Andrew H. S. Lee | G. Callagy | D. Purnell | A. Katayama | R. Millican-Slater | Ciara Murray | N. Badr | Karim Eldib | Cian Martyn